Indoco Remedies said that it has secured GCP and GLP accreditation from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for AnaCipher, the company’s clinical research organization in Hyderabad.

The accreditation was given following a virtual inspection undertaken from 4th – 7th May and 10th – 11th May, 2021.

The inspection covered all the phases of bioequivalence studies, said Indoco Remedies, a Mumbai-based pharma company.

Aditi Kare Panandikar — Managing Director of Indoco Remedies said: “This is an exciting step in our journey of excellence and a validation of our adherence to delivering quality services to our customers worldwide.”

AnaCipher CRO is a clinical research facility, which is spread over 30,000sft. It is equipped with 98 beds and is used for providing clinical trial solutions and carrying out bioequivalence and bioavailability (BA/BE) studies.

  Aditi Kare Panandikar, AnaCipher, Hyderabad, India, Indoco Remedies, UK MHRA